{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T16:14:01Z","timestamp":1783440841065,"version":"3.54.6"},"reference-count":169,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T00:00:00Z","timestamp":1759622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T00:00:00Z","timestamp":1759622400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Protein J"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s10930-025-10289-2","type":"journal-article","created":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T19:57:51Z","timestamp":1759694271000},"page":"691-716","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Unlocking the Therapeutic Potential of Cyclic Peptide-Based Nanocarriers for Enhanced Colon Cancer Treatment"],"prefix":"10.1007","volume":"44","author":[{"given":"Vedhapriya","family":"Souresh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Srikayalsamyukktha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Harini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yudhesh","family":"Saravanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5140-5989","authenticated-orcid":false,"given":"Rupachandra","family":"Saravanakumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,5]]},"reference":[{"key":"10289_CR1","doi-asserted-by":"publisher","first-page":"808","DOI":"10.4251\/wjgo.v12.i8.808","volume":"12","author":"S Chakrabarti","year":"2020","unstructured":"Chakrabarti S, Peterson CY, Sriram D, Mahipal A (2020) Early stage colon cancer: current treatment standards, evolving paradigms, and future directions. World J Gastrointest Oncol 12:808\u2013832. https:\/\/doi.org\/10.4251\/wjgo.v12.i8.808","journal-title":"World J Gastrointest Oncol"},{"key":"10289_CR2","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492","journal-title":"CA Cancer J Clin"},{"key":"10289_CR3","doi-asserted-by":"publisher","first-page":"759","DOI":"10.2174\/1389203719666180111150008","volume":"19","author":"B Yavari","year":"2018","unstructured":"Yavari B, Mahjub R, Saidijam M, Raigani M, Soleimani M (2018) The potential use of peptides in cancer treatment. Curr Protein Pept Sci 19:759\u2013770. https:\/\/doi.org\/10.2174\/1389203719666180111150008","journal-title":"Curr Protein Pept Sci"},{"key":"10289_CR4","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.3390\/molecules23082080","volume":"23","author":"MA Abdalla","year":"2018","unstructured":"Abdalla MA, McGaw LJ (2018) Natural cyclic peptides as an attractive modality for therapeutics: a mini review. Molecules 23:2080. https:\/\/doi.org\/10.3390\/molecules23082080","journal-title":"Molecules"},{"key":"10289_CR5","doi-asserted-by":"publisher","first-page":"130","DOI":"10.3390\/ijms22010130","volume":"22","author":"A Malki","year":"2020","unstructured":"Malki A, ElRuz RA, Gupta I, Allouch A, Vranic S, Al Moustafa A-E (2020) Molecular mechanisms of colon cancer progression and metastasis: recent insights and advancements. Int J Mol Sci 22:130. https:\/\/doi.org\/10.3390\/ijms22010130","journal-title":"Int J Mol Sci"},{"key":"10289_CR6","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.2217\/nnm-2020-0220","volume":"15","author":"N Mehrotra","year":"2020","unstructured":"Mehrotra N, Kharbanda S, Singh H (2020) Peptide-based combination nanoformulations for cancer therapy. Nanomedicine 15:2201\u20132217. https:\/\/doi.org\/10.2217\/nnm-2020-0220","journal-title":"Nanomedicine"},{"key":"10289_CR7","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.cbpa.2017.02.006","volume":"38","author":"A Zorzi","year":"2017","unstructured":"Zorzi A, Deyle K, Heinis C (2017) Cyclic peptide therapeutics: past, present and future. Curr Opin Chem Biol 38:24\u201329. https:\/\/doi.org\/10.1016\/j.cbpa.2017.02.006","journal-title":"Curr Opin Chem Biol"},{"key":"10289_CR8","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.3390\/pharmaceutics13091433","volume":"13","author":"I Gaurav","year":"2021","unstructured":"Gaurav I, Wang X, Thakur A, Iyaswamy A, Thakur S, Chen X, Kumar G, Li M, Yang Z (2021) Peptide-conjugated nano delivery systems for therapy and diagnosis of cancer. Pharmaceutics 13:1433. https:\/\/doi.org\/10.3390\/pharmaceutics13091433","journal-title":"Pharmaceutics"},{"key":"10289_CR9","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.jconrel.2019.10.031","volume":"316","author":"X Jiang","year":"2019","unstructured":"Jiang X, Fan X, Xu W, Zhao C, Wu H, Zhang R, Wu G (2019) Self-assembled peptide nanoparticles responsive to multiple tumor microenvironment triggers provide highly efficient targeted delivery and release of antitumor drug. J Control Release 316:196\u2013207. https:\/\/doi.org\/10.1016\/j.jconrel.2019.10.031","journal-title":"J Control Release"},{"key":"10289_CR10","doi-asserted-by":"publisher","first-page":"2770","DOI":"10.3390\/pharmaceutics15122770","volume":"15","author":"Z Xia","year":"2023","unstructured":"Xia Z, Mu W, Yuan S, Fu S, Liu Y, Zhang N (2023) Cell membrane biomimetic nano-delivery systems for cancer therapy. Pharmaceutics 15:2770. https:\/\/doi.org\/10.3390\/pharmaceutics15122770","journal-title":"Pharmaceutics"},{"key":"10289_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s40580-018-0170-1","author":"W Jeong","year":"2018","unstructured":"Jeong W, Bu J, Kubiatowicz LJ, Chen SS, Kim Y, Hong S (2018) Peptide\u2013nanoparticle conjugates: a next generation of diagnostic and therapeutic platforms? Nano Convergence. https:\/\/doi.org\/10.1186\/s40580-018-0170-1","journal-title":"Nano Convergence"},{"key":"10289_CR12","doi-asserted-by":"publisher","first-page":"11605","DOI":"10.1021\/jacs.4c02745","volume":"146","author":"B Choi","year":"2024","unstructured":"Choi B, Acu\u00f1a A, Link AJ (2024) Cyclic peptides from Graspetide biosynthesis and native chemical ligation. J Am Chem Soc 146:11605\u201311609. https:\/\/doi.org\/10.1021\/jacs.4c02745","journal-title":"J Am Chem Soc"},{"key":"10289_CR13","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1039\/c2np20085f","volume":"30","author":"PG Arnison","year":"2013","unstructured":"Arnison PG, Bibb MJ, Bierbaum G, Bowers AA, Bugni TS, Bulaj G, Camarero JA, Campopiano DJ, Challis GL, Clardy J, Cotter PD, Craik DJ, Dawson M, Dittmann E, Donadio S, Dorrestein PC, Entian K-D, Fischbach MA, Garavelli JS, G\u00f6ransson U, Gruber CW, Haft DH, Hemscheidt TK, Hertweck C, Hill C, Horswill AR, Jaspars M, Kelly WL, Klinman JP, Kuipers OP, Link AJ, Liu W, Marahiel MA, Mitchell DA, Moll GN, Moore BS, M\u00fcller R, Nair SK, Nes IF, Norris GE, Olivera BM, Onaka H, Patchett ML, Piel J, Reaney MJT, Rebuffat S, Ross RP, Sahl H-G, Schmidt EW, Selsted ME, Severinov K, Shen B, Sivonen K, Smith L, Stein T, S\u00fcssmuth RD, Tagg JR, Tang G-L, Truman AW, Vederas JC, Walsh CT, Walton JD, Wenzel SC, Willey JM, van der Donk WA (2013) Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclature. Nat Prod Rep 30:108\u2013160. https:\/\/doi.org\/10.1039\/c2np20085f","journal-title":"Nat Prod Rep"},{"key":"10289_CR14","doi-asserted-by":"publisher","first-page":"10961","DOI":"10.1073\/pnas.1813993115","volume":"115","author":"RD Kersten","year":"2018","unstructured":"Kersten RD, Weng J-K (2018) Gene-guided discovery and engineering of branched cyclic peptides in plants. Proc Natl Acad Sci 115:10961\u201310969. https:\/\/doi.org\/10.1073\/pnas.1813993115","journal-title":"Proc Natl Acad Sci"},{"key":"10289_CR15","doi-asserted-by":"publisher","first-page":"3770","DOI":"10.1002\/anie.201609079","volume":"56","author":"RD S\u00fcssmuth","year":"2017","unstructured":"S\u00fcssmuth RD, Mainz A (2017) Nonribosomal peptide synthesis\u2014principles and prospects. Angew Chem Int Ed 56:3770\u20133821. https:\/\/doi.org\/10.1002\/anie.201609079","journal-title":"Angew Chem Int Ed"},{"key":"10289_CR16","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1021\/acs.accounts.5b00156","volume":"48","author":"JD Hegemann","year":"2015","unstructured":"Hegemann JD, Zimmermann M, Xie X, Marahiel MA (2015) Lasso peptides: an intriguing class of bacterial natural products. Acc Chem Res 48:1909\u20131919. https:\/\/doi.org\/10.1021\/acs.accounts.5b00156","journal-title":"Acc Chem Res"},{"key":"10289_CR17","doi-asserted-by":"publisher","first-page":"996","DOI":"10.3390\/ph16070996","volume":"16","author":"L Costa","year":"2023","unstructured":"Costa L, Sousa E, Fernandes C (2023) Cyclic peptides in pipeline: what future for these great molecules. Pharmaceuticals 16:996. https:\/\/doi.org\/10.3390\/ph16070996","journal-title":"Pharmaceuticals"},{"key":"10289_CR18","doi-asserted-by":"publisher","first-page":"28776","DOI":"10.1039\/d4cp02759k","volume":"26","author":"T Kurita","year":"2024","unstructured":"Kurita T, Numata K (2024) The structural and functional impacts of rationally designed cyclic peptides on self-assembly-mediated functionality. Phys Chem Chem Phys 26:28776\u201328792. https:\/\/doi.org\/10.1039\/d4cp02759k","journal-title":"Phys Chem Chem Phys"},{"key":"10289_CR19","doi-asserted-by":"publisher","first-page":"19","DOI":"10.4062\/biomolther.2012.20.1.019","volume":"20","author":"S-H Joo","year":"2012","unstructured":"Joo S-H (2012) Cyclic peptides as therapeutic agents and biochemical tools. Biomol Ther 20:19\u201326. https:\/\/doi.org\/10.4062\/biomolther.2012.20.1.019","journal-title":"Biomol Ther"},{"key":"10289_CR20","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbae190","author":"L Liu","year":"2024","unstructured":"Liu L, Yang L, Cao S, Gao Z, Yang B, Zhang G, Zhu R, Wu D (2024) CyclicPepedia: a knowledge base of natural and synthetic cyclic peptides. Brief Bioinform. https:\/\/doi.org\/10.1093\/bib\/bbae190","journal-title":"Brief Bioinform"},{"key":"10289_CR21","doi-asserted-by":"publisher","first-page":"2700","DOI":"10.1016\/j.bmc.2017.06.052","volume":"26","author":"JL Lau","year":"2018","unstructured":"Lau JL, Dunn MK (2018) Therapeutic peptides: historical perspectives, current development trends, and future directions. Bioorg Med Chem 26:2700\u20132707. https:\/\/doi.org\/10.1016\/j.bmc.2017.06.052","journal-title":"Bioorg Med Chem"},{"key":"10289_CR22","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1021\/cr040699h","volume":"106","author":"N-H Tan","year":"2006","unstructured":"Tan N-H, Zhou J (2006) Plant cyclopeptides. Chem Rev 106:840\u2013895. https:\/\/doi.org\/10.1021\/cr040699h","journal-title":"Chem Rev"},{"key":"10289_CR23","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.cbpa.2017.01.018","volume":"38","author":"DJ Craik","year":"2017","unstructured":"Craik DJ, Du J (2017) Cyclotides as drug design scaffolds. Curr Opin Chem Biol 38:8\u201316. https:\/\/doi.org\/10.1016\/j.cbpa.2017.01.018","journal-title":"Curr Opin Chem Biol"},{"key":"10289_CR24","doi-asserted-by":"publisher","first-page":"8695","DOI":"10.1021\/acs.jafc.6b03725","volume":"64","author":"H Huang","year":"2016","unstructured":"Huang H, Krishnan HB, Pham Q, Yu LL, Wang TTY (2016) Soy and gut microbiota: interaction and implication for human health. J Agric Food Chem 64:8695\u20138709. https:\/\/doi.org\/10.1021\/acs.jafc.6b03725","journal-title":"J Agric Food Chem"},{"key":"10289_CR25","doi-asserted-by":"publisher","first-page":"e40563","DOI":"10.1016\/j.heliyon.2024.e40563","volume":"10","author":"M Bidram","year":"2024","unstructured":"Bidram M, Ganjalikhany MR (2024) Bioactive peptides from food science to pharmaceutical industries: their mechanism of action, potential role in cancer treatment and available resources. Heliyon 10:e40563. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e40563","journal-title":"Heliyon"},{"key":"10289_CR26","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.3390\/molecules24091829","volume":"24","author":"D Guo","year":"2019","unstructured":"Guo D, Wang Y, Wang J, Song L, Wang Z, Mao B, Tan N (2019) RA-XII suppresses the development and growth of liver cancer by inhibition of lipogenesis via scap-dependent SREBP supression. Molecules 24:1829. https:\/\/doi.org\/10.3390\/molecules24091829","journal-title":"Molecules"},{"key":"10289_CR27","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1002\/ptr.7482","volume":"36","author":"Q Lin","year":"2022","unstructured":"Lin Q, Liu M, Yue GG, Cheung MK, Lai Z, Kwok FH, Lee JK, Wang Z, Lau CB, Tan N (2022) Anti-inflammatory activities of natural cyclopeptide RA-XII in colitis-associated colon cancer mouse model and its effect on gut microbiome. Phytother Res 36:2641\u20132659. https:\/\/doi.org\/10.1002\/ptr.7482","journal-title":"Phytother Res"},{"key":"10289_CR28","doi-asserted-by":"publisher","first-page":"108776","DOI":"10.1016\/j.abb.2021.108776","volume":"701","author":"Y Yang","year":"2021","unstructured":"Yang Y, Mao H, Chen L, Li L (2021) Targeting signal pathways triggered by cyclic peptides in cancer: current trends and future challenges. Arch Biochem Biophys 701:108776. https:\/\/doi.org\/10.1016\/j.abb.2021.108776","journal-title":"Arch Biochem Biophys"},{"key":"10289_CR29","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.bbrc.2019.03.088","volume":"512","author":"Y Wang","year":"2019","unstructured":"Wang Y, Guo D, He J, Song L, Chen H, Zhang Z, Tan N (2019) Inhibition of fatty acid synthesis arrests colorectal neoplasm growth and metastasis: anti-cancer therapeutical effects of natural cyclopeptide RA-XII. Biochem Biophys Res Commun 512:819\u2013824. https:\/\/doi.org\/10.1016\/j.bbrc.2019.03.088","journal-title":"Biochem Biophys Res Commun"},{"key":"10289_CR30","doi-asserted-by":"publisher","first-page":"113438","DOI":"10.1016\/j.jep.2020.113438","volume":"266","author":"J Wang","year":"2021","unstructured":"Wang J, Wang J, Li L, Feng L, Wang Y-R, Wang Z, Tan N-H (2021) RA-XII, a bicyclic hexapeptidic glucoside isolated from Rubia yunnanensis Diels, exerts antitumor activity by inhibiting protective autophagy and activating Akt-mTOR pathway in colorectal cancer cells. J Ethnopharmacol 266:113438. https:\/\/doi.org\/10.1016\/j.jep.2020.113438","journal-title":"J Ethnopharmacol"},{"key":"10289_CR31","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.3892\/ol.2017.6017","volume":"13","author":"X Wan","year":"2017","unstructured":"Wan X, Liu H, Sun Y, Zhang J, Chen X, Chen N (2017) Lunasin: a promising polypeptide for the prevention and treatment of cancer. Oncol Lett 13:3997\u20134001. https:\/\/doi.org\/10.3892\/ol.2017.6017","journal-title":"Oncol Lett"},{"key":"10289_CR32","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.3390\/nu10091211","volume":"10","author":"C Chatterjee","year":"2018","unstructured":"Chatterjee C, Gleddie S, Xiao C-W (2018) Soybean bioactive peptides and their functional properties. Nutrients 10:1211. https:\/\/doi.org\/10.3390\/nu10091211","journal-title":"Nutrients"},{"key":"10289_CR33","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1002\/mnfr.201000419","volume":"55","author":"VP Dia","year":"2011","unstructured":"Dia VP, de Mejia EG (2011) Lunasin induces apoptosis and modifies the expression of genes associated with extracellular matrix and cell adhesion in human metastatic colon cancer cells. Mol Nutr Food Res 55:623\u2013634. https:\/\/doi.org\/10.1002\/mnfr.201000419","journal-title":"Mol Nutr Food Res"},{"key":"10289_CR34","doi-asserted-by":"publisher","first-page":"966","DOI":"10.2741\/e676","volume":"E5","author":"H Kobayashi","year":"2013","unstructured":"Kobayashi H (2013) Prevention of cancer and inflammation by protease inhibitors. Front Biosci E5:966\u2013973. https:\/\/doi.org\/10.2741\/e676","journal-title":"Front Biosci"},{"key":"10289_CR35","doi-asserted-by":"publisher","first-page":"421","DOI":"10.3390\/ph13120421","volume":"13","author":"A Gitlin-Domagalska","year":"2020","unstructured":"Gitlin-Domagalska A, Maciejewska A, D\u0119bowski D (2020) Bowman-birk inhibitors: insights into family of multifunctional proteins and peptides with potential therapeutical applications. Pharmaceuticals 13:421. https:\/\/doi.org\/10.3390\/ph13120421","journal-title":"Pharmaceuticals"},{"key":"10289_CR36","doi-asserted-by":"publisher","first-page":"9187","DOI":"10.3390\/ijms24119187","volume":"24","author":"A Kaufman-Szymczyk","year":"2023","unstructured":"Kaufman-Szymczyk A, Kaczmarek W, Fabianowska-Majewska K, Lubecka-Gajewska K (2023) Lunasin and its epigenetic impact in cancer chemoprevention. Int J Mol Sci 24:9187. https:\/\/doi.org\/10.3390\/ijms24119187","journal-title":"Int J Mol Sci"},{"key":"10289_CR37","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.3390\/molecules21121747","volume":"21","author":"M Shan","year":"2016","unstructured":"Shan M, Yu S, Yan H, Chen P, Zhang L, Ding A (2016) A review of the botany, phytochemistry, pharmacology and toxicology of rubiae radix et rhizoma. Molecules 21:1747. https:\/\/doi.org\/10.3390\/molecules21121747","journal-title":"Molecules"},{"key":"10289_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-0743-2","author":"Z Wang","year":"2018","unstructured":"Wang Z, Zhao S, Song L, Pu Y, Wang Q, Zeng G, Liu X, Bai M, Li S, Gao F, Chen L, Wang C, Tan N (2018) Natural cyclopeptide RA-V inhibits the NF-\u03baB signaling pathway by targeting TAK1. Cell Death Dis. https:\/\/doi.org\/10.1038\/s41419-018-0743-2","journal-title":"Cell Death Dis"},{"key":"10289_CR39","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.taap.2012.12.010","volume":"267","author":"X-Y Fang","year":"2013","unstructured":"Fang X-Y, Chen W, Fan J-T, Song R, Wang L, Gu Y-H, Zeng G-Z, Shen Y, Wu X-F, Tan N-H, Xu Q, Sun Y (2013) Plant cyclopeptide RA-V kills human breast cancer cells by inducing mitochondria-mediated apoptosis through blocking PDK1\u2013AKT interaction. Toxicol Appl Pharmacol 267:95\u2013103. https:\/\/doi.org\/10.1016\/j.taap.2012.12.010","journal-title":"Toxicol Appl Pharmacol"},{"key":"10289_CR40","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2020.11529","author":"L Jiang","year":"2020","unstructured":"Jiang L, Li J, Zhang C, Shang Y, Lin J (2020) YAP-mediated crosstalk between the Wnt and Hippo signaling pathways. Mol Med Rep. https:\/\/doi.org\/10.3892\/mmr.2020.11529","journal-title":"Mol Med Rep"},{"key":"10289_CR41","doi-asserted-by":"publisher","first-page":"735","DOI":"10.3390\/molecules26030735","volume":"26","author":"P Balachandran","year":"2021","unstructured":"Balachandran P, Ibrahim MA, Zhang J, Wang M, Pasco DS, Muhammad I (2021) Crosstalk of cancer signaling pathways by cyclic hexapeptides and anthraquinones from Rubia cordifolia. Molecules 26:735. https:\/\/doi.org\/10.3390\/molecules26030735","journal-title":"Molecules"},{"key":"10289_CR42","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1042\/bst20200881","volume":"49","author":"NL Daly","year":"2021","unstructured":"Daly NL, Wilson DT (2021) Plant derived cyclic peptides. Biochem Soc Trans 49:1279\u20131285. https:\/\/doi.org\/10.1042\/bst20200881","journal-title":"Biochem Soc Trans"},{"key":"10289_CR43","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1002\/cbic.201100450","volume":"12","author":"L Sando","year":"2011","unstructured":"Sando L, Troeira Henriques S, Foley F, Simonsen SM, Daly NL, Hall KN, Gustafson KR, Aguilar M, Craik DJ (2011) A synthetic mirror image of Kalata B1 reveals that cyclotide activity is independent of a protein receptor. ChemBioChem 12:2456\u20132462. https:\/\/doi.org\/10.1002\/cbic.201100450","journal-title":"ChemBioChem"},{"key":"10289_CR44","doi-asserted-by":"publisher","first-page":"11623","DOI":"10.1021\/ja405108p","volume":"135","author":"Y Ji","year":"2013","unstructured":"Ji Y, Majumder S, Millard M, Borra R, Bi T, Elnagar AY, Neamati N, Shekhtman A, Camarero JA (2013) In vivo activation of the p53 tumor suppressor pathway by an engineered cyclotide. J Am Chem Soc 135:11623\u201311633. https:\/\/doi.org\/10.1021\/ja405108p","journal-title":"J Am Chem Soc"},{"key":"10289_CR45","doi-asserted-by":"publisher","first-page":"5089","DOI":"10.1016\/j.bmcl.2017.10.051","volume":"27","author":"JA Camarero","year":"2017","unstructured":"Camarero JA (2017) Cyclotides, a versatile ultrastable micro-protein scaffold for biotechnological applications. Bioorg Med Chem Lett 27:5089\u20135099. https:\/\/doi.org\/10.1016\/j.bmcl.2017.10.051","journal-title":"Bioorg Med Chem Lett"},{"key":"10289_CR46","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1016\/j.bmcl.2012.01.058","volume":"22","author":"Y Tong","year":"2012","unstructured":"Tong Y, Luo J-G, Wang R, Wang X-B, Kong L-Y (2012) New cyclic peptides with osteoblastic proliferative activity from Dianthus superbus. Bioorg Med Chem Lett 22:1908\u20131911. https:\/\/doi.org\/10.1016\/j.bmcl.2012.01.058","journal-title":"Bioorg Med Chem Lett"},{"key":"10289_CR47","doi-asserted-by":"publisher","first-page":"108902","DOI":"10.1016\/j.cbi.2019.108902","volume":"315","author":"M Gholibeikian","year":"2020","unstructured":"Gholibeikian M, Bamoniri A, HoushdarTehrani MH, Fatemeh Mirjalili BB, Bijanzadeh HR (2020) Structure-activity relationship studies of Longicalcynin A analogues, as anticancer cyclopeptides. Chem Biol Interact 315:108902. https:\/\/doi.org\/10.1016\/j.cbi.2019.108902","journal-title":"Chem Biol Interact"},{"key":"10289_CR48","doi-asserted-by":"publisher","first-page":"8","DOI":"10.5897\/jcreo2013.0102","volume":"5","author":"W Ahmad","year":"2013","unstructured":"Ahmad W (2013) Solid-phase total synthesis of cyclic pentapeptide Longicalycinin A, by using 2-chlorotrityl chloride resin. J Cancer Res Exp Oncol 5:8\u201319. https:\/\/doi.org\/10.5897\/jcreo2013.0102","journal-title":"J Cancer Res Exp Oncol"},{"key":"10289_CR49","first-page":"956","volume":"17","author":"MH HoushdarTehrani","year":"2018","unstructured":"HoushdarTehrani MH, Bamoniri A, Mirjalili BBF, Gholibeikian M (2018) Synthesis of linear and cyclic disulfide heptapeptides of Longicalycinin A and evaluation of toxicity on cancerous cells HepG2 and HT-29. Iran J Pharm Res 17:956\u2013963","journal-title":"Iran J Pharm Res"},{"key":"10289_CR50","doi-asserted-by":"publisher","first-page":"491","DOI":"10.3390\/md17090491","volume":"17","author":"SAM Khalifa","year":"2019","unstructured":"Khalifa SAM, Elias N, Farag MA, Chen L, Saeed A, Hegazy M-EF, Moustafa MS, Abd El-Wahed A, Al-Mousawi SM, Musharraf SG, Chang F-R, Iwasaki A, Suenaga K, Alajlani M, G\u00f6ransson U, El-Seedi HR (2019) Marine natural products: a source of novel anticancer drugs. Mar Drugs 17:491. https:\/\/doi.org\/10.3390\/md17090491","journal-title":"Mar Drugs"},{"key":"10289_CR51","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1039\/c4np00144c","volume":"32","author":"JW Blunt","year":"2015","unstructured":"Blunt JW, Copp BR, Keyzers RA, Munro MHG, Prinsep MR (2015) Marine natural products. Nat Prod Rep 32:116\u2013211. https:\/\/doi.org\/10.1039\/c4np00144c","journal-title":"Nat Prod Rep"},{"key":"10289_CR52","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1016\/j.jksus.2019.12.003","volume":"32","author":"AR Ganesan","year":"2020","unstructured":"Ganesan AR, Mohanram MSG, Balasubramanian B, Ho Kim I, Seedevi P, Mohan K, Kanagasabai S, Valan Arasu M, Abdullah Al-Dhabi N, Ignacimuthu S (2020) Marine invertebrates\u2019 proteins: a recent update on functional property. J King Saud Univ Sci 32:1496\u20131502. https:\/\/doi.org\/10.1016\/j.jksus.2019.12.003","journal-title":"J King Saud Univ Sci"},{"key":"10289_CR53","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.5530\/pj.2020.12.202","volume":"12","author":"N Srinivasan","year":"2020","unstructured":"Srinivasan N, Dhanalakshmi S, Pandian P (2020) Encouraging leads from marine sources for cancer therapy a review approach. Pharmacogn J 12:1475\u20131481. https:\/\/doi.org\/10.5530\/pj.2020.12.202","journal-title":"Pharmacogn J"},{"key":"10289_CR54","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3390\/md18010020","volume":"18","author":"SA Dyshlovoy","year":"2019","unstructured":"Dyshlovoy SA, Honecker F (2019) Marine compounds and cancer: the first two decades of XXI century. Mar Drugs 18:20. https:\/\/doi.org\/10.3390\/md18010020","journal-title":"Mar Drugs"},{"key":"10289_CR55","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ijbiomac.2017.07.001","volume":"105","author":"J Zhu","year":"2017","unstructured":"Zhu J, Xu J, Wang Y, Li C, Chen Z, Song L, Gao J, Yu R (2017) Purification and structural characterization of a novel anti-tumor protein from Arca inflata. Int J Biol Macromol 105:103\u2013110. https:\/\/doi.org\/10.1016\/j.ijbiomac.2017.07.001","journal-title":"Int J Biol Macromol"},{"key":"10289_CR56","doi-asserted-by":"publisher","first-page":"2346","DOI":"10.3390\/ijms21072346","volume":"21","author":"J Yue","year":"2020","unstructured":"Yue J, L\u00f3pez JM (2020) Understanding MAPK signaling pathways in apoptosis. Int J Mol Sci 21:2346. https:\/\/doi.org\/10.3390\/ijms21072346","journal-title":"Int J Mol Sci"},{"key":"10289_CR57","doi-asserted-by":"publisher","first-page":"110","DOI":"10.3390\/md20020110","volume":"20","author":"C Li","year":"2022","unstructured":"Li C, Zhang S, Zhu J, Huang W, Luo Y, Shi H, Yu D, Chen L, Song L, Yu R (2022) A novel peptide derived from Arca inflata induces apoptosis in colorectal cancer cells through mitochondria and the p38 MAPK pathway. Mar Drugs 20:110. https:\/\/doi.org\/10.3390\/md20020110","journal-title":"Mar Drugs"},{"key":"10289_CR58","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.3390\/md9101995","volume":"9","author":"T-C Huang","year":"2011","unstructured":"Huang T-C, Lee J-F, Chen J-Y (2011) Pardaxin, an antimicrobial peptide, triggers caspase-dependent and ros-mediated apoptosis in HT-1080 cells. Mar Drugs 9:1995\u20132009. https:\/\/doi.org\/10.3390\/md9101995","journal-title":"Mar Drugs"},{"key":"10289_CR59","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.canlet.2010.10.001","volume":"300","author":"J Liu","year":"2011","unstructured":"Liu J, Lin M, Yu J, Liu B, Bao J (2011) Targeting apoptotic and autophagic pathways for cancer therapeutics. Cancer Lett 300:105\u2013114. https:\/\/doi.org\/10.1016\/j.canlet.2010.10.001","journal-title":"Cancer Lett"},{"key":"10289_CR60","doi-asserted-by":"publisher","first-page":"885","DOI":"10.2174\/1389203717666160724200849","volume":"18","author":"B Negi","year":"2017","unstructured":"Negi B, Kumar D, Rawat DS (2017) Marine peptides as anticancer agents: a remedy to mankind by nature. Curr Protein Peptide Sci 18:885\u2013904. https:\/\/doi.org\/10.2174\/1389203717666160724200849","journal-title":"Curr Protein Peptide Sci"},{"key":"10289_CR61","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3390\/md19070363","volume":"19","author":"G Gao","year":"2021","unstructured":"Gao G, Wang Y, Hua H, Li D, Tang C (2021) Marine antitumor peptide dolastatin 10: biological activity, structural modification and synthetic chemistry. Mar Drugs 19:363. https:\/\/doi.org\/10.3390\/md19070363","journal-title":"Mar Drugs"},{"key":"10289_CR62","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1002\/iub.25","volume":"60","author":"E Pasquier","year":"2008","unstructured":"Pasquier E, Kavallaris M (2008) Microtubules: a dynamic target in cancer therapy. IUBMB Life 60:165\u2013170. https:\/\/doi.org\/10.1002\/iub.25","journal-title":"IUBMB Life"},{"key":"10289_CR63","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1021\/np800568j","volume":"72","author":"DGI Kingston","year":"2009","unstructured":"Kingston DGI (2009) Tubulin-interactive natural products as anticancer agents. J Nat Prod 72:507\u2013515. https:\/\/doi.org\/10.1021\/np800568j","journal-title":"J Nat Prod"},{"key":"10289_CR64","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1016\/j.tet.2017.03.006","volume":"73","author":"X Wang","year":"2017","unstructured":"Wang X, Dong S, Feng D, Chen Y, Ma M, Hu W (2017) Synthesis and biological activity evaluation of dolastatin 10 analogues with N-terminal modifications. Tetrahedron 73:2255\u20132266. https:\/\/doi.org\/10.1016\/j.tet.2017.03.006","journal-title":"Tetrahedron"},{"key":"10289_CR65","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3390\/cancers16010036","volume":"16","author":"M Librizzi","year":"2023","unstructured":"Librizzi M, Martino C, Mauro M, Abruscato G, Arizza V, Vazzana M, Luparello C (2023) Natural anticancer peptides from marine animal species: evidence from in vitro cell model systems. Cancers (Basel) 16:36. https:\/\/doi.org\/10.3390\/cancers16010036","journal-title":"Cancers (Basel)"},{"key":"10289_CR66","doi-asserted-by":"publisher","first-page":"3166","DOI":"10.1021\/acs.jnatprod.0c00815","volume":"83","author":"J Lee","year":"2020","unstructured":"Lee J, ChathurikaDB G, Kim GJ, Hillman PF, Lee C, Lee EY, Choi H, Kim H, Nam S-J, Fenical W (2020) Androsamide, a cyclic tetrapeptide from a marine Nocardiopsis sp., suppresses motility of colorectal cancer cells. J Nat Prod 83:3166\u20133172. https:\/\/doi.org\/10.1021\/acs.jnatprod.0c00815","journal-title":"J Nat Prod"},{"key":"10289_CR67","doi-asserted-by":"publisher","first-page":"6842","DOI":"10.2174\/0929867331666230821102521","volume":"31","author":"X Zha","year":"2024","unstructured":"Zha X, Ji R, Zhou S (2024) Marine bacteria: a source of novel bioactive natural products. Curr Med Chem 31:6842\u20136854. https:\/\/doi.org\/10.2174\/0929867331666230821102521","journal-title":"Curr Med Chem"},{"key":"10289_CR68","doi-asserted-by":"publisher","DOI":"10.1002\/chin.200913195","author":"A Plaza","year":"2009","unstructured":"Plaza A, Bifulco G, Keffer JL, Lloyd JR, Baker HL, Bewley CA (2009) Cheminform abstract: celebesides A\u2013C and theopapuamides B\u2013D, depsipeptides from an Indonesian sponge that inhibit HIV-1 entry. ChemInform. https:\/\/doi.org\/10.1002\/chin.200913195","journal-title":"ChemInform"},{"key":"10289_CR69","doi-asserted-by":"publisher","first-page":"41","DOI":"10.4062\/biomolther.2018.047","volume":"27","author":"X Han","year":"2019","unstructured":"Han X, Kang KA, Piao MJ, Zhen AX, Hyun YJ, Kim HM, Ryu YS, Hyun JW (2019) Shikonin exerts cytotoxic effects in human colon cancers by inducing apoptotic cell death via the endoplasmic reticulum and mitochondria-mediated pathways. Biomol Ther 27:41\u201347. https:\/\/doi.org\/10.4062\/biomolther.2018.047","journal-title":"Biomol Ther"},{"key":"10289_CR70","doi-asserted-by":"publisher","DOI":"10.1002\/ardp.202100034","author":"R Dahiya","year":"2021","unstructured":"Dahiya R, Dahiya S, Kumar P, Kumar RV, Dahiya S, Kumar S, Saharan R, Basu P, Mitra A, Sharma A, Kashaw SK, Patel JK (2021) Structural and biological aspects of natural bridged macrobicyclic peptides from marine resources. Arch Pharm (Weinheim). https:\/\/doi.org\/10.1002\/ardp.202100034","journal-title":"Arch Pharm (Weinheim)"},{"key":"10289_CR71","doi-asserted-by":"publisher","first-page":"12931","DOI":"10.3390\/ijms241612931","volume":"24","author":"NTT Nh\u00e0n","year":"2023","unstructured":"Nh\u00e0n NTT, Yamada T, Yamada KH (2023) Peptide-based agents for cancer treatment: current applications and future directions. Int J Mol Sci 24:12931. https:\/\/doi.org\/10.3390\/ijms241612931","journal-title":"Int J Mol Sci"},{"key":"10289_CR72","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.3390\/cancers12051271","volume":"12","author":"K Wang","year":"2020","unstructured":"Wang K, Li M, Qin J, Sun G, Dai L, Wang P, Ye H, Shi J, Cheng L, Yang Q, Qiu C, Jiang D, Wang X, Zhang J (2020) Serological biomarkers for early detection of hepatocellular carcinoma: a focus on autoantibodies against tumor-associated antigens encoded by cancer driver genes. Cancers 12:1271. https:\/\/doi.org\/10.3390\/cancers12051271","journal-title":"Cancers"},{"key":"10289_CR73","doi-asserted-by":"publisher","first-page":"18","DOI":"10.4062\/biomolther.2019.082","volume":"28","author":"J-S Choi","year":"2020","unstructured":"Choi J-S, Joo SH (2020) Recent trends in cyclic peptides as therapeutic agents and biochemical tools. Biomol Ther 28:18\u201324. https:\/\/doi.org\/10.4062\/biomolther.2019.082","journal-title":"Biomol Ther"},{"key":"10289_CR74","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1021\/acscombsci.7b00194","volume":"20","author":"M-K Shin","year":"2018","unstructured":"Shin M-K, Hyun Y-J, Lee JH, Lim H-S (2018) Comparison of cell permeability of cyclic peptoids and linear peptoids. ACS Comb Sci 20:237\u2013242. https:\/\/doi.org\/10.1021\/acscombsci.7b00194","journal-title":"ACS Comb Sci"},{"key":"10289_CR75","doi-asserted-by":"publisher","first-page":"526","DOI":"10.2174\/1568026618666180518092333","volume":"18","author":"SJS Rubin","year":"2018","unstructured":"Rubin SJS, Qvit N (2018) Backbone-cyclized peptides: a critical review. Curr Top Med Chem 18:526\u2013555. https:\/\/doi.org\/10.2174\/1568026618666180518092333","journal-title":"Curr Top Med Chem"},{"key":"10289_CR76","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.ejps.2017.12.005","volume":"114","author":"E Schartmann","year":"2018","unstructured":"Schartmann E, Schemmert S, Ziehm T, Leithold LHE, Jiang N, Tusche M, Joni Shah N, Langen K-J, Kutzsche J, Willbold D, Willuweit A (2018) Comparison of blood-brain barrier penetration efficiencies between linear and cyclic all-d-enantiomeric peptides developed for the treatment of Alzheimer\u2019s disease. Eur J Pharm Sci 114:93\u2013102. https:\/\/doi.org\/10.1016\/j.ejps.2017.12.005","journal-title":"Eur J Pharm Sci"},{"key":"10289_CR77","doi-asserted-by":"publisher","first-page":"10241","DOI":"10.1021\/acs.chemrev.9b00008","volume":"119","author":"PG Dougherty","year":"2019","unstructured":"Dougherty PG, Sahni A, Pei D (2019) Understanding cell penetration of cyclic peptides. Chem Rev 119:10241\u201310287. https:\/\/doi.org\/10.1021\/acs.chemrev.9b00008","journal-title":"Chem Rev"},{"key":"10289_CR78","doi-asserted-by":"publisher","first-page":"7337","DOI":"10.1007\/s00210-024-03129-0","volume":"397","author":"BK Chagaleti","year":"2024","unstructured":"Chagaleti BK, Baby K, Pe\u00f1a-Corona SI, Leyva-G\u00f3mez G, Sm S, Naveen NR, Jose J, Aldahish AA, Sharifi-Rad J, Calina D (2024) Anti-cancer properties of Sansalvamide A, its derivatives, and analogs: an updated review. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 397:7337\u20137351. https:\/\/doi.org\/10.1007\/s00210-024-03129-0","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"10289_CR79","doi-asserted-by":"publisher","first-page":"5625","DOI":"10.1016\/j.bmc.2006.04.031","volume":"14","author":"TJ Styers","year":"2006","unstructured":"Styers TJ, Kekec A, Rodriguez R, Brown JD, Cajica J, Pan P-S, Parry E, Carroll CL, Medina I, Corral R, Lapera S, Otrubova K, Pan C-M, McGuire KL, McAlpine SR (2006) Synthesis of Sansalvamide A derivatives and their cytotoxicity in the MSS colon cancer cell line HT-29. Bioorg Med Chem 14:5625\u20135631. https:\/\/doi.org\/10.1016\/j.bmc.2006.04.031","journal-title":"Bioorg Med Chem"},{"key":"10289_CR80","doi-asserted-by":"publisher","first-page":"10317","DOI":"10.3390\/ijms221910317","volume":"22","author":"B Birbo","year":"2021","unstructured":"Birbo B, Madu EE, Madu CO, Jain A, Lu Y (2021) Role of HSP90 in cancer. Int J Mol Sci 22:10317. https:\/\/doi.org\/10.3390\/ijms221910317","journal-title":"Int J Mol Sci"},{"key":"10289_CR81","doi-asserted-by":"publisher","first-page":"4536","DOI":"10.1021\/acs.orglett.7b02112","volume":"19","author":"C Poock","year":"2017","unstructured":"Poock C, Kalesse M (2017) Total synthesis of nannocystin ax. Org Lett 19:4536\u20134539. https:\/\/doi.org\/10.1021\/acs.orglett.7b02112","journal-title":"Org Lett"},{"key":"10289_CR82","doi-asserted-by":"publisher","first-page":"10287","DOI":"10.1002\/ange.201505069","volume":"127","author":"P Krastel","year":"2015","unstructured":"Krastel P, Roggo S, Schirle M, Ross NT, Perruccio F, Aspesi P Jr, Aust T, Buntin K, Estoppey D, Liechty B, Mapa F, Memmert K, Miller H, Pan X, Riedl R, Thibaut C, Thomas J, Wagner T, Weber E, Xie X, Schmitt EK, Hoepfner D (2015) Nannocystin a: an elongation factor 1 inhibitor from myxobacteria with differential anti-cancer properties. Angew Chem 127:10287\u201310292. https:\/\/doi.org\/10.1002\/ange.201505069","journal-title":"Angew Chem"},{"key":"10289_CR83","doi-asserted-by":"publisher","first-page":"4428","DOI":"10.3390\/molecules27144428","volume":"27","author":"D Ramadhani","year":"2022","unstructured":"Ramadhani D, Maharani R, Gazzali AM, Muchtaridi M (2022) Cyclic peptides for the treatment of cancers: a review. Molecules 27:4428. https:\/\/doi.org\/10.3390\/molecules27144428","journal-title":"Molecules"},{"key":"10289_CR84","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1007\/s10822-017-0066-x","volume":"31","author":"PA S\u00e1nchez-Murcia","year":"2017","unstructured":"S\u00e1nchez-Murcia PA, Cort\u00e9s-Cabrera \u00c1, Gago F (2017) Structural rationale for the cross-resistance of tumor cells bearing the A399V variant of elongation factor eEF1A1 to the structurally unrelated didemnin B, ternatin, nannocystin A and ansatrienin B. J Comput Aided Mol Des 31:915\u2013928. https:\/\/doi.org\/10.1007\/s10822-017-0066-x","journal-title":"J Comput Aided Mol Des"},{"key":"10289_CR85","doi-asserted-by":"publisher","first-page":"7264","DOI":"10.3390\/ijms25137264","volume":"25","author":"LV Bauso","year":"2024","unstructured":"Bauso LV, La Fauci V, Muna\u00f2 S, Bonfiglio D, Armeli A, Maimone N, Longo C, Calabrese G (2024) Biological activity of natural and synthetic peptides as anticancer agents. Int J Mol Sci 25:7264. https:\/\/doi.org\/10.3390\/ijms25137264","journal-title":"Int J Mol Sci"},{"key":"10289_CR86","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jare.2023.09.003","volume":"61","author":"RP Aganja","year":"2024","unstructured":"Aganja RP, Sivasankar C, Lee JH (2024) AI-2 quorum sensing controlled delivery of cytolysin-A by tryptophan auxotrophic low-endotoxic Salmonella and its anticancer effects in CT26 mice with colon cancer. J Adv Res 61:83\u2013100. https:\/\/doi.org\/10.1016\/j.jare.2023.09.003","journal-title":"J Adv Res"},{"key":"10289_CR87","doi-asserted-by":"publisher","DOI":"10.1177\/15330338231178403","author":"A Dey","year":"2023","unstructured":"Dey A, Mitra A, Pathak S, Prasad S, Zhang AS, Zhang H, Sun X-F, Banerjee A (2023) Recent advancements, limitations, and future perspectives of the use of personalized medicine in treatment of colon cancer. Technol Cancer Res Treat. https:\/\/doi.org\/10.1177\/15330338231178403","journal-title":"Technol Cancer Res Treat"},{"key":"10289_CR88","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.7150\/ijms.6960","volume":"10","author":"G Guan","year":"2013","unstructured":"Guan G, Zhao M, Liu L, Jin C, Sun K, Zhang D, Yu D, Cao H, Lu Y-Q, Wen L (2013) Salmonella typhimurium mediated delivery of Apoptin in human laryngeal cancer. Int J Med Sci 10:1639\u20131648. https:\/\/doi.org\/10.7150\/ijms.6960","journal-title":"Int J Med Sci"},{"key":"10289_CR89","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/aps.2010.224","volume":"32","author":"N Yang","year":"2011","unstructured":"Yang N, Li S, L\u00fc Y, Chen L, Ren D (2011) Attenuated Salmonella typhimurium carrying shRNA-expressing vectors elicit RNA interference in murine bladder tumors. Acta Pharmacol Sin 32:368\u2013374. https:\/\/doi.org\/10.1038\/aps.2010.224","journal-title":"Acta Pharmacol Sin"},{"key":"10289_CR90","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3390\/metabo12020141","volume":"12","author":"S Lee","year":"2022","unstructured":"Lee S, Jeong SY, Nguyen DL, So JE, Kim KH, Kim JH, Han SJ, Suh S-S, Lee JH, Youn UJ (2022) Stereocalpin b, a new cyclic depsipeptide from the Antarctic lichen Ramalina terebrata. Metabolites 12:141. https:\/\/doi.org\/10.3390\/metabo12020141","journal-title":"Metabolites"},{"key":"10289_CR91","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.3390\/molecules22081361","volume":"22","author":"S-S Suh","year":"2017","unstructured":"Suh S-S, Kim T, Kim J, Hong J-M, Nguyen T, Han S, Youn U, Yim J, Kim I-C (2017) Anticancer activity of ramalin, a secondary metabolite from the Antarctic lichen Ramalina terebrata, against colorectal cancer cells. Molecules 22:1361. https:\/\/doi.org\/10.3390\/molecules22081361","journal-title":"Molecules"},{"key":"10289_CR92","doi-asserted-by":"publisher","first-page":"4260","DOI":"10.1111\/1462-2920.15605","volume":"23","author":"G Singh","year":"2021","unstructured":"Singh G, Calchera A, Schulz M, Drechsler M, Bode HB, Schmitt I, Dal Grande F (2021) Climate-specific biosynthetic gene clusters in populations of a lichen-forming fungus. Environ Microbiol 23:4260\u20134275. https:\/\/doi.org\/10.1111\/1462-2920.15605","journal-title":"Environ Microbiol"},{"key":"10289_CR93","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1002\/ptr.5703","volume":"30","author":"H Park","year":"2016","unstructured":"Park H, Jang YJ, Yim J, Lee H, Pyo S (2016) Ramalin isolated from ramalina terebrata attenuates atopic dermatitis-like skin lesions in balb\/c mice and cutaneous immune responses in keratinocytes and mast cells. Phytother Res 30:1978\u20131987. https:\/\/doi.org\/10.1002\/ptr.5703","journal-title":"Phytother Res"},{"key":"10289_CR94","doi-asserted-by":"publisher","DOI":"10.1038\/srep10316","author":"G Dey","year":"2015","unstructured":"Dey G, Bharti R, Dhanarajan G, Das S, Dey KK, Kumar BNP, Sen R, Mandal M (2015) Marine lipopeptide iturin A inhibits Akt mediated GSK3\u03b2 and FoxO3a signaling and triggers apoptosis in breast cancer. Sci Rep. https:\/\/doi.org\/10.1038\/srep10316","journal-title":"Sci Rep"},{"key":"10289_CR95","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s10989-020-10105-8","volume":"27","author":"M Rofeal","year":"2020","unstructured":"Rofeal M, El-Malek FA (2020) Valorization of lipopeptides biosurfactants as anticancer agents. Int J Pept Res Ther 27:447\u2013455. https:\/\/doi.org\/10.1007\/s10989-020-10105-8","journal-title":"Int J Pept Res Ther"},{"key":"10289_CR96","doi-asserted-by":"publisher","first-page":"6414","DOI":"10.1002\/jcp.27377","volume":"234","author":"H Zhao","year":"2018","unstructured":"Zhao H, Xu X, Lei S, Shao D, Jiang C, Shi J, Zhang Y, Liu L, Lei S, Sun H, Huang Q (2018) Iturin A-like lipopeptides from Bacillus subtilis trigger apoptosis, paraptosis, and autophagy in Caco-2 cells. J Cell Physiol 234:6414\u20136427. https:\/\/doi.org\/10.1002\/jcp.27377","journal-title":"J Cell Physiol"},{"key":"10289_CR97","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3390\/md14020038","volume":"14","author":"E Gudi\u00f1a","year":"2016","unstructured":"Gudi\u00f1a E, Teixeira J, Rodrigues L (2016) Biosurfactants produced by marine microorganisms with therapeutic applications. Mar Drugs 14:38. https:\/\/doi.org\/10.3390\/md14020038","journal-title":"Mar Drugs"},{"key":"10289_CR98","doi-asserted-by":"publisher","first-page":"12321","DOI":"10.1021\/jo401974g","volume":"78","author":"S Um","year":"2013","unstructured":"Um S, Choi TJ, Kim H, Kim BY, Kim S-H, Lee SK, Oh K-B, Shin J, Oh D-C (2013) Ohmyungsamycins A and B: cytotoxic and antimicrobial cyclic peptides produced by Streptomyces sp. from a volcanic island. J Org Chem 78:12321\u201312329. https:\/\/doi.org\/10.1021\/jo401974g","journal-title":"J Org Chem"},{"key":"10289_CR99","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1021\/acs.jnatprod.9b00918","volume":"83","author":"WS Byun","year":"2020","unstructured":"Byun WS, Kim S, Shin Y-H, Kim WK, Oh D-C, Lee SK (2020) Antitumor activity of ohmyungsamycin A through the regulation of the skp2-p27 axis and MCM4 in human colorectal cancer cells. J Nat Prod 83:118\u2013126. https:\/\/doi.org\/10.1021\/acs.jnatprod.9b00918","journal-title":"J Nat Prod"},{"key":"10289_CR100","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/s1534-5807(04)00131-5","volume":"6","author":"K Nakayama","year":"2004","unstructured":"Nakayama K, Nagahama H, Minamishima YA, Miyake S, Ishida N, Hatakeyama S, Kitagawa M, Iemura S, Natsume T, Nakayama KI (2004) Skp2-mediated degradation of p27 regulates progression into mitosis. Dev Cell 6:661\u2013672. https:\/\/doi.org\/10.1016\/s1534-5807(04)00131-5","journal-title":"Dev Cell"},{"key":"10289_CR101","doi-asserted-by":"publisher","DOI":"10.1186\/1478-811x-8-31","author":"GV Chaitanya","year":"2010","unstructured":"Chaitanya GV, Alexander JS, Babu PP (2010) PARP-1 cleavage fragments: signatures of cell-death proteases in neurodegeneration. Cell Commun Signal. https:\/\/doi.org\/10.1186\/1478-811x-8-31","journal-title":"Cell Commun Signal"},{"key":"10289_CR102","unstructured":"Wahyudi H (2014) Development of lead structures that are cytotoxic and are derived from macrocycle natural products. http:\/\/hdl.handle.net\/1959.4\/53751"},{"key":"10289_CR103","doi-asserted-by":"publisher","first-page":"599","DOI":"10.3390\/md19110599","volume":"19","author":"S Jiang","year":"2021","unstructured":"Jiang S, Zhang E, Ruan H, Ma J, Zhao X, Zhu Y, Xie X, Han N, Li J, Zhang H, Xie W, Li X (2021) Actinomycin v induces apoptosis associated with mitochondrial and PI3K\/AKT pathways in human CRC cells. Mar Drugs 19:599. https:\/\/doi.org\/10.3390\/md19110599","journal-title":"Mar Drugs"},{"key":"10289_CR104","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.cell.2017.07.029","volume":"170","author":"DA Fruman","year":"2017","unstructured":"Fruman DA, Chiu H, Hopkins BD, Bagrodia S, Cantley LC, Abraham RT (2017) The PI3K pathway in human disease. Cell 170:605\u2013635. https:\/\/doi.org\/10.1016\/j.cell.2017.07.029","journal-title":"Cell"},{"key":"10289_CR105","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.semcdb.2019.05.022","volume":"98","author":"M Abate","year":"2020","unstructured":"Abate M, Festa A, Falco M, Lombardi A, Luce A, Grimaldi A, Zappavigna S, Sperlongano P, Irace C, Caraglia M, Misso G (2020) Mitochondria as playmakers of apoptosis, autophagy and senescence. Semin Cell Dev Biol 98:139\u2013153. https:\/\/doi.org\/10.1016\/j.semcdb.2019.05.022","journal-title":"Semin Cell Dev Biol"},{"key":"10289_CR106","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/nature04869","volume":"441","author":"RJ Shaw","year":"2006","unstructured":"Shaw RJ, Cantley LC (2006) Ras, PI(3)K and mTOR signalling controls tumour cell growth. Nature 441:424\u2013430. https:\/\/doi.org\/10.1038\/nature04869","journal-title":"Nature"},{"key":"10289_CR107","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.cellsig.2007.07.010","volume":"20","author":"A Parcellier","year":"2008","unstructured":"Parcellier A, Tintignac LA, Zhuravleva E, Hemmings BA (2008) PKB and the mitochondria: AKTing on apoptosis. Cell Signal 20:21\u201330. https:\/\/doi.org\/10.1016\/j.cellsig.2007.07.010","journal-title":"Cell Signal"},{"key":"10289_CR108","doi-asserted-by":"publisher","first-page":"349","DOI":"10.3390\/md20060349","volume":"20","author":"N Han","year":"2022","unstructured":"Han N, Li J, Li X (2022) Natural marine products: anti-colorectal cancer in vitro and in vivo. Mar Drugs 20:349. https:\/\/doi.org\/10.3390\/md20060349","journal-title":"Mar Drugs"},{"key":"10289_CR109","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1111\/imr.12519","volume":"276","author":"LP Andrews","year":"2017","unstructured":"Andrews LP, Marciscano AE, Drake CG, Vignali DAA (2017) LAG3 (CD223) as a cancer immunotherapy target. Immunol Rev 276:80\u201396. https:\/\/doi.org\/10.1111\/imr.12519","journal-title":"Immunol Rev"},{"key":"10289_CR110","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1016\/j.apsb.2023.12.011","volume":"14","author":"Y Qian","year":"2024","unstructured":"Qian Y, Sun Y, Shi P, Zhou X, Zhang Q, Dong Q, Jin S, Qiu L, Niu X, Zhou X, Zhao W, Wu Y, Zhai W, Gao Y (2024) Development of LAG-3\/FGL1 blocking peptide and combination with radiotherapy for cancer immunotherapy. Acta Pharm Sin B 14:1150\u20131165. https:\/\/doi.org\/10.1016\/j.apsb.2023.12.011","journal-title":"Acta Pharm Sin B"},{"key":"10289_CR111","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/j.apsb.2020.01.005","volume":"10","author":"W Zhai","year":"2020","unstructured":"Zhai W, Zhou X, Wang H, Li W, Chen G, Sui X, Li G, Qi Y, Gao Y (2020) A novel cyclic peptide targeting LAG-3 for cancer immunotherapy by activating antigen-specific CD8+ T cell responses. Acta Pharm Sin B 10:1047\u20131060. https:\/\/doi.org\/10.1016\/j.apsb.2020.01.005","journal-title":"Acta Pharm Sin B"},{"key":"10289_CR112","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.3390\/cells10102655","volume":"10","author":"I Navasardyan","year":"2021","unstructured":"Navasardyan I, Bonavida B (2021) Regulation of T cells in cancer by nitric oxide. Cells 10:2655. https:\/\/doi.org\/10.3390\/cells10102655","journal-title":"Cells"},{"key":"10289_CR113","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-024-02892-9","author":"X Cong","year":"2024","unstructured":"Cong X, Zhang Z, Li H, Yang Y-G, Zhang Y, Sun T (2024) Nanocarriers for targeted drug delivery in the vascular system: focus on endothelium. J Nanobiotechnol. https:\/\/doi.org\/10.1186\/s12951-024-02892-9","journal-title":"J Nanobiotechnol"},{"key":"10289_CR114","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1435133","author":"X Feng","year":"2024","unstructured":"Feng X, Jia P, Zhang D (2024) Nanocarrier drug delivery system: promising platform for targeted depression therapy. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2024.1435133","journal-title":"Front Pharmacol"},{"key":"10289_CR115","doi-asserted-by":"publisher","first-page":"517","DOI":"10.2174\/1570159x20666220706121412","volume":"21","author":"S Sharma","year":"2023","unstructured":"Sharma S, Dang S (2023) Nanocarrier-based drug delivery to brain: interventions of surface modification. Curr Neuropharmacol 21:517\u2013535. https:\/\/doi.org\/10.2174\/1570159x20666220706121412","journal-title":"Curr Neuropharmacol"},{"key":"10289_CR116","doi-asserted-by":"publisher","first-page":"12633","DOI":"10.2147\/ijn.s487303","volume":"19","author":"C Wang","year":"2024","unstructured":"Wang C, Shen Z, Chen Y, Wang Y, Zhou X, Chen X, Li Y, Zhang P, Zhang Q (2024) Research progress on cyclic-peptide functionalized nanoparticles for tumor-penetrating delivery. Int J Nanomed 19:12633\u201312652. https:\/\/doi.org\/10.2147\/ijn.s487303","journal-title":"Int J Nanomed"},{"key":"10289_CR117","doi-asserted-by":"publisher","first-page":"295","DOI":"10.3390\/molecules23020295","volume":"23","author":"A Borrelli","year":"2018","unstructured":"Borrelli A, Tornesello A, Tornesello M, Buonaguro F (2018) Cell penetrating peptides as molecular carriers for anti-cancer agents. Molecules 23:295. https:\/\/doi.org\/10.3390\/molecules23020295","journal-title":"Molecules"},{"key":"10289_CR118","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.3390\/molecules30071572","volume":"30","author":"H Omidian","year":"2025","unstructured":"Omidian H, Cubeddu LX, Wilson RL (2025) Peptide-functionalized nanomedicine: advancements in drug delivery, diagnostics, and biomedical applications. Molecules 30:1572. https:\/\/doi.org\/10.3390\/molecules30071572","journal-title":"Molecules"},{"key":"10289_CR119","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-021-00999-x","author":"Y Wang","year":"2021","unstructured":"Wang Y, Zhang X, Wan K, Zhou N, Wei G, Su Z (2021) Supramolecular peptide nano-assemblies for cancer diagnosis and therapy: from molecular design to material synthesis and function-specific applications. J Nanobiotechnology. https:\/\/doi.org\/10.1186\/s12951-021-00999-x","journal-title":"J Nanobiotechnology"},{"key":"10289_CR120","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1021\/acs.jpcb.2c06751","volume":"127","author":"VB Kumar","year":"2023","unstructured":"Kumar VB, Ozguney B, Vlachou A, Chen Y, Gazit E, Tamamis P (2023) Peptide self-assembled nanocarriers for cancer drug delivery. J Phys Chem B 127:1857\u20131871. https:\/\/doi.org\/10.1021\/acs.jpcb.2c06751","journal-title":"J Phys Chem B"},{"issue":"2","key":"10289_CR121","doi-asserted-by":"publisher","first-page":"99","DOI":"10.29228\/jrp.1","volume":"25","author":"S Srivastava","year":"2021","unstructured":"Srivastava S, Sharma V, Bhushan B et al (2021) Nanocarriers for protein and peptide delivery: Recent advances and progress. J Res Pharm 25(2):99\u2013116. https:\/\/doi.org\/10.29228\/jrp.1","journal-title":"J Res Pharm"},{"key":"10289_CR122","doi-asserted-by":"publisher","first-page":"12071","DOI":"10.3390\/ijms232012071","volume":"23","author":"J Ke","year":"2022","unstructured":"Ke J, Zhang J, Li J, Liu J, Guan S (2022) Design of cyclic peptide-based nanospheres and the delivery of siRNA. Int J Mol Sci 23:12071. https:\/\/doi.org\/10.3390\/ijms232012071","journal-title":"Int J Mol Sci"},{"key":"10289_CR123","doi-asserted-by":"publisher","first-page":"4622","DOI":"10.3390\/ijms25094622","volume":"25","author":"M Albani","year":"2024","unstructured":"Albani M, Fassi EMA, Moretti RM, Garofalo M, Montagnani Marelli M, Roda G, Sgrignani J, Cavalli A, Grazioso G (2024) Computational design of novel cyclic peptides endowed with autophagy-inhibiting activity on cancer cell lines. Int J Mol Sci 25:4622. https:\/\/doi.org\/10.3390\/ijms25094622","journal-title":"Int J Mol Sci"},{"key":"10289_CR124","doi-asserted-by":"publisher","first-page":"169","DOI":"10.21873\/anticanres.13938","volume":"40","author":"H Okuyama","year":"2019","unstructured":"Xu Y, Yao Y, Wang L, Chen H, Tan N (2021) Hyaluronic acid coated liposomes co-delivery of natural cyclic peptide RA-XII and mitochondrial targeted photosensitizer for highly selective precise combined treatment of colon cancer. Int J Nanomed 16:4929\u20134942. https:\/\/doi.org\/10.2147\/ijn.s311577","journal-title":"Anticancer Res"},{"key":"10289_CR125","doi-asserted-by":"publisher","DOI":"10.1002\/psc.3385","author":"X Du","year":"2021","unstructured":"Piri-Gharaghie T, Ghourchian H, Rezaeizadeh G, Kabiri H, Rajaei N, Dhiaa AM, Ghajari G, Bahari R (2024) (S)-3-(3,4-Dihydroxybenzyl) piperazine-2,5-dione (cyclo-Gly-L-DOPA or CG-Nio-CGLD) peptide loaded in chitosan glutamate-coated niosomes as anti-Colorectal cancer activity. BMC Pharmacol Toxicol. https:\/\/doi.org\/10.1186\/s40360-024-00766-2","journal-title":"J Pept Sci"},{"key":"10289_CR126","doi-asserted-by":"publisher","DOI":"10.1038\/srep31539","author":"X Yu","year":"2016","unstructured":"Song Z, Lin Y, Zhang X, Feng C, Lu Y, Gao Y, Dong C (2017) Cyclic RGD peptide-modified liposomal drug delivery system for targeted oral apatinib administration: enhanced cellular uptake and improved therapeutic effects. Int J Nanomed 12:1941\u20131958. https:\/\/doi.org\/10.2147\/ijn.s125573","journal-title":"Sci Rep"},{"key":"10289_CR127","doi-asserted-by":"publisher","unstructured":"Khazaei Monfared Y, Mahmoudian M, Cecone C, Caldera F, Zakeri-Milani P, Matencio A, Trotta F (2022) Stabilization and anticancer enhancing activity of the peptide nisin by cyclodextrin-based nanosponges against colon and breast cancer cells. Polymers 14:594. https:\/\/doi.org\/10.3390\/polym14030594","DOI":"10.3390\/polym14030594"},{"key":"10289_CR128","doi-asserted-by":"publisher","first-page":"6436","DOI":"10.1021\/acsanm.9b01392","volume":"2","author":"F Biscaglia","year":"2019","unstructured":"Biscaglia F, Ripani G, Rajendran S, Benna C, Mocellin S, Bocchinfuso G, Meneghetti M, Palleschi A, Gobbo M (2019) Gold nanoparticle aggregates functionalized with cyclic RGD peptides for targeting and imaging of colorectal cancer cells. ACS Appl Nano Mater 2:6436\u20136444. https:\/\/doi.org\/10.1021\/acsanm.9b01392","journal-title":"ACS Appl Nano Mater"},{"key":"10289_CR129","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1039\/c5cc06661a","volume":"52","author":"T Ishii","year":"2016","unstructured":"Ishii T, Miyata K, Anraku Y, Naito M, Yi Y, Jinbo T, Takae S, Fukusato Y, Hori M, Osada K, Kataoka K (2016) Enhanced target recognition of nanoparticles by cocktail PEGylation with chains of varying lengths. Chem Commun 52:1517\u20131519. https:\/\/doi.org\/10.1039\/c5cc06661a","journal-title":"Chem Commun"},{"key":"10289_CR130","doi-asserted-by":"publisher","first-page":"5019","DOI":"10.1021\/acs.molpharmaceut.8b00612","volume":"15","author":"G Su","year":"2018","unstructured":"Su G, Jiang H, Xu B, Yu Y, Chen X (2018) Effects of protein corona on active and passive targeting of cyclic RGD peptide-functionalized pegylation nanoparticles. Mol Pharm 15:5019\u20135030. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.8b00612","journal-title":"Mol Pharm"},{"key":"10289_CR131","doi-asserted-by":"publisher","first-page":"31032","DOI":"10.1021\/acsami.8b10452","volume":"10","author":"A S\u00e1nchez","year":"2018","unstructured":"S\u00e1nchez A, Ovejero Paredes K, Ruiz-Cabello J, Mart\u00ednez-Ru\u00edz P, Pingarr\u00f3n JM, Villalonga R, Filice M (2018) Hybrid decorated core@shell janus nanoparticles as a flexible platform for targeted multimodal molecular bioimaging of cancer. ACS Appl Mater Interfaces 10:31032\u201331043. https:\/\/doi.org\/10.1021\/acsami.8b10452","journal-title":"ACS Appl Mater Interfaces"},{"issue":"7","key":"10289_CR132","doi-asserted-by":"publisher","DOI":"10.3390\/nano10071353","volume":"10","author":"L Mart\u00ednez-Jothar","year":"2020","unstructured":"Mart\u00ednez-Jothar L, Barendrecht AD, de Graaff AM, Oliveira S, van Nostrum CF, Schiffelers RM, Hennink WE, Fens MHAM (2020) Endothelial cell targeting by cRGD-functionalized polymeric nanoparticles under static and flow conditions. Nanomaterials 10(7):1353. https:\/\/doi.org\/10.3390\/nano10071353","journal-title":"Nanomaterials"},{"key":"10289_CR133","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-021-01191-x","author":"Y Hua","year":"2021","unstructured":"Hua Y, Wang Y, Kang X, Xu F, Han Z, Zhang C, Wang Z-Y, Liu J-Q, Zhao X, Chen X, Zang S-Q (2021) A multifunctional AIE gold cluster-based theranostic system: tumor-targeted imaging and Fenton reaction-assisted enhanced radiotherapy. J Nanobiotechnol. https:\/\/doi.org\/10.1186\/s12951-021-01191-x","journal-title":"J Nanobiotechnol"},{"key":"10289_CR134","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.3390\/polym12051122","volume":"12","author":"I Krabicov\u00e1","year":"2020","unstructured":"Krabicov\u00e1 I, Appleton SL, Tannous M, Hoti G, Caldera F, Rubin Pedrazzo A, Cecone C, Cavalli R, Trotta F (2020) History of cyclodextrin nanosponges. Polymers 12:1122. https:\/\/doi.org\/10.3390\/polym12051122","journal-title":"Polymers"},{"key":"10289_CR135","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.3390\/polym13111684","volume":"13","author":"A Matencio","year":"2021","unstructured":"Matencio A, Hoti G, Monfared Y, Rezayat A, Pedrazzo A, Caldera F, Trotta F (2021) Cyclodextrin monomers and polymers for drug activity enhancement. Polymers 13:1684. https:\/\/doi.org\/10.3390\/polym13111684","journal-title":"Polymers"},{"key":"10289_CR136","doi-asserted-by":"publisher","first-page":"115763","DOI":"10.1016\/j.carbpol.2019.115763","volume":"231","author":"A Matencio","year":"2020","unstructured":"Matencio A, Dhakar NK, Bessone F, Musso G, Cavalli R, Dianzani C, Garc\u00eda-Carmona F, L\u00f3pez-Nicol\u00e1s JM, Trotta F (2020) Study of oxyresveratrol complexes with insoluble cyclodextrin based nanosponges: developing a novel way to obtain their complexation constants and application in an anticancer study. Carbohydr Polym 231:115763. https:\/\/doi.org\/10.1016\/j.carbpol.2019.115763","journal-title":"Carbohydr Polym"},{"key":"10289_CR137","doi-asserted-by":"publisher","first-page":"478","DOI":"10.3390\/ma14030478","volume":"14","author":"G Hoti","year":"2021","unstructured":"Hoti G, Caldera F, Cecone C, Rubin Pedrazzo A, Anceschi A, Appleton SL, Khazaei Monfared Y, Trotta F (2021) Effect of the cross-linking density on the swelling and rheological behavior of ester-bridged \u03b2-cyclodextrin nanosponges. Materials 14:478. https:\/\/doi.org\/10.3390\/ma14030478","journal-title":"Materials"},{"key":"10289_CR138","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.3390\/ijms26031213","volume":"26","author":"I Krabicov\u00e1","year":"2025","unstructured":"Krabicov\u00e1 I, Khazaei Monfared Y, Caldera F, Mahmoudian M, Hobbs C, Santalucia R, Appleton SL, Matencio A, Zakeri-Milani P, Trotta F (2025) Leveraging cholesterol-functionalized cyclodextrin nanosponges for enhanced drug delivery in cancer cells. Int J Mol Sci 26:1213. https:\/\/doi.org\/10.3390\/ijms26031213","journal-title":"Int J Mol Sci"},{"key":"10289_CR139","doi-asserted-by":"publisher","first-page":"e08674","DOI":"10.1016\/j.heliyon.2021.e08674","volume":"8","author":"Y Herdiana","year":"2022","unstructured":"Herdiana Y, Wathoni N, Shamsuddin S, Muchtaridi M (2022) Drug release study of the chitosan-based nanoparticles. Heliyon 8:e08674. https:\/\/doi.org\/10.1016\/j.heliyon.2021.e08674","journal-title":"Heliyon"},{"key":"10289_CR140","doi-asserted-by":"publisher","first-page":"3126","DOI":"10.1007\/s12010-023-04687-4","volume":"196","author":"H Ghourchian","year":"2023","unstructured":"Ghourchian H, Pecho RDC, Karimi-Dehkordi M, Mazandarani A, Ghajari G, Piri-Gharaghie T (2023) Novel niosome-encapsulated 2,5-diketopiperazine (BHPPD): synthesis, formulation, and anti-breast cancer activity. Appl Biochem Biotechnol 196:3126\u20133147. https:\/\/doi.org\/10.1007\/s12010-023-04687-4","journal-title":"Appl Biochem Biotechnol"},{"key":"10289_CR141","doi-asserted-by":"publisher","first-page":"20","DOI":"10.52547\/jct.12.1.20","volume":"12","author":"S Khezri","year":"2021","unstructured":"Khezri S, Baharara J, Amini E (2021) Evaluation of the effect of menthol on apoptosis induction and Bax and Bcl2 gene expression in the CT-26 colon cancer cell line. J Cell Tissue 12:20\u201328. https:\/\/doi.org\/10.52547\/jct.12.1.20","journal-title":"J Cell Tissue"},{"key":"10289_CR142","doi-asserted-by":"publisher","first-page":"100332","DOI":"10.1016\/j.carpta.2023.100332","volume":"6","author":"G Nerli","year":"2023","unstructured":"Nerli G, Robla S, Bartalesi M, Luceri C, D\u2019Ambrosio M, Csaba N, Maestrelli F (2023) Chitosan coated niosomes for nose-to-brain delivery of clonazepam: formulation, stability and permeability studies. Carbohydr Polym Technol Appl 6:100332. https:\/\/doi.org\/10.1016\/j.carpta.2023.100332","journal-title":"Carbohydr Polym Technol Appl"},{"key":"10289_CR143","doi-asserted-by":"publisher","DOI":"10.1186\/s12645-020-00059-3","author":"M Wiranowska","year":"2020","unstructured":"Wiranowska M, Singh R, Falahat R, Williams E, Johnson JO, Alcantar N (2020) Preferential drug delivery to tumor cells than normal cells using a tunable niosome\u2013chitosan double package nanodelivery system: a novel in vitro model. Cancer Nanotechnol. https:\/\/doi.org\/10.1186\/s12645-020-00059-3","journal-title":"Cancer Nanotechnol"},{"key":"10289_CR144","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.6800","author":"H Javid","year":"2024","unstructured":"Javid H, Oryani MA, Rezagholinejad N, Esparham A, Tajaldini M, Karimi-Shahri M (2024) RGD peptide in cancer targeting: benefits, challenges, solutions, and possible integrin\u2013RGD interactions. Cancer Med. https:\/\/doi.org\/10.1002\/cam4.6800","journal-title":"Cancer Med"},{"key":"10289_CR145","doi-asserted-by":"publisher","DOI":"10.2147\/ijn.s33541","author":"Z Chen","year":"2012","unstructured":"Chen Z, Deng J, Zhao Y, Tao T (2012) Cyclic RGD peptide-modified liposomal drug delivery system: Enhanced cellular uptake in vitro and improved pharmacokinetics in rats. Int J Nanomed. https:\/\/doi.org\/10.2147\/ijn.s33541","journal-title":"Int J Nanomed"},{"key":"10289_CR146","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1021\/bc500505c","volume":"26","author":"H-Q Yin","year":"2015","unstructured":"Yin H-Q, Bi F-L, Gan F (2015) Rapid synthesis of cyclic RGD conjugated gold nanoclusters for targeting and fluorescence imaging of melanoma A375 cells. Bioconjug Chem 26:243\u2013249. https:\/\/doi.org\/10.1021\/bc500505c","journal-title":"Bioconjug Chem"},{"key":"10289_CR147","doi-asserted-by":"publisher","first-page":"133","DOI":"10.5306\/wjco.v6.i5.133","volume":"6","author":"B Pabla","year":"2015","unstructured":"Pabla B (2015) Colon cancer and the epidermal growth factor receptor: current treatment paradigms, the importance of diet, and the role of chemoprevention. World J Clin Oncol 6:133. https:\/\/doi.org\/10.5306\/wjco.v6.i5.133","journal-title":"World J Clin Oncol"},{"key":"10289_CR148","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.jconrel.2017.04.030","volume":"255","author":"H-R Jia","year":"2017","unstructured":"Jia H-R, Jiang Y-W, Zhu Y-X, Li Y-H, Wang H-Y, Han X, Yu Z-W, Gu N, Liu P, Chen Z, Wu F-G (2017) Plasma membrane activatable polymeric nanotheranostics with self-enhanced light-triggered photosensitizer cellular influx for photodynamic cancer therapy. J Control Release 255:231\u2013241. https:\/\/doi.org\/10.1016\/j.jconrel.2017.04.030","journal-title":"J Control Release"},{"issue":"16","key":"10289_CR149","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.3390\/nano12162851","volume":"12","author":"M Curcio","year":"2022","unstructured":"Curcio M, Vittorio O, Bell JL, Iemma F, Nicoletta FP, Cirillo G (2022) Hyaluronic acid within self-assembling nanoparticles: endless possibilities for targeted cancer therapy. Nanomaterials 12(16):2851. https:\/\/doi.org\/10.3390\/nano12162851","journal-title":"Nanomaterials"},{"key":"10289_CR150","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1039\/c9bm00905a","volume":"8","author":"Y Yao","year":"2020","unstructured":"Yao Y, Feng L, Wang Z, Chen H, Tan N (2020) Programmed delivery of cyclopeptide RA-V and antisense oligonucleotides for combination therapy on hypoxic tumors and for therapeutic self-monitoring. Biomater Sci 8:256\u2013265. https:\/\/doi.org\/10.1039\/c9bm00905a","journal-title":"Biomater Sci"},{"key":"10289_CR151","doi-asserted-by":"publisher","DOI":"10.1080\/2162402x.2020.1806680","author":"CC Schimanski","year":"2020","unstructured":"Schimanski CC, Kasper S, Hegewisch-Becker S, Schr\u00f6der J, Overkamp F, Kullmann F, Bechstein WO, V\u00f6hringer M, \u00d6llinger R, Lordick F, Heinemann V, Gei\u00dfler M, Schulz-Abelius A, Bernhard H, Sch\u00f6n MR, Greil R, Galle P, Lang H, Schmidtmann I, Moehler M (2020) Adjuvant MUC vaccination with tecemotide after resection of colorectal liver metastases: a randomized, double-blind, placebo-controlled, multicenter AIO phase II trial (LICC). Oncoimmunology. https:\/\/doi.org\/10.1080\/2162402x.2020.1806680","journal-title":"Oncoimmunology"},{"key":"10289_CR152","doi-asserted-by":"publisher","first-page":"123","DOI":"10.2166\/wst.2020.559","volume":"83","author":"EG Bull","year":"2020","unstructured":"Taniguchi H, Iwasa S, Yamazaki K, Yoshino T, Kiryu C, Naka Y, Liew EL, Sakata Y (2017) Phase 1 study of OCV\u2010C02, a peptide vaccine consisting of two peptide epitopes for refractory metastatic colorectal cancer. Cancer Science 108:1013\u20131021.  https:\/\/doi.org\/10.1111\/cas.13227","journal-title":"Water Sci Technol"},{"key":"10289_CR153","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-12-63","volume":"12","author":"S Hazama","year":"2014","unstructured":"Hazama S, Nakamura Y, Takenouchi H, Suzuki N, Tsunedomi R, Inoue Y, Tokuhisa Y, Iizuka N, Yoshino S, Takeda K, Shinozaki H, Kamiya A, Furukawa H, Oka M (2014) A phase I study of combination vaccine treatment of five therapeutic epitope-peptides for metastatic colorectal cancer; safety, immunological response, and clinical outcome. J Transl Med 12:63. https:\/\/doi.org\/10.1186\/1479-5876-12-63","journal-title":"J Transl Med"},{"key":"10289_CR154","doi-asserted-by":"publisher","first-page":"CT264\u2013CT264","DOI":"10.1158\/1538-7445.am2025-ct264","volume":"85","author":"HH Wang","year":"2025","unstructured":"Wang HH, Huff A, Haldar S, Berg M, Thoburn C, Bever K, Pishvaian M, Lee V, Le D, Christenson E, Baretti M, Durham J, Thomas A, Yarchoan M, Laheru D, Nauroth J, Lu J, Wang H, Jaffee EM, Azad N, Zaidi N (2025) Abstract CT264: mutant KRAS peptide vaccine combined with ipilimumab\/nivolumab in advanced mismatch repair proficient\/microsatellite stable (MMRp\/MSS) colorectal cancer: preliminary analysis from a phase I study. Cancer Res 85:CT264\u2013CT264. https:\/\/doi.org\/10.1158\/1538-7445.am2025-ct264","journal-title":"Cancer Res"},{"key":"10289_CR155","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17091512","volume":"17","author":"R Miao","year":"2025","unstructured":"Miao R, Yu J, Kim RD (2025) Targeting the KRAS oncogene for patients with metastatic colorectal cancer. Cancers 17:1512. https:\/\/doi.org\/10.3390\/cancers17091512","journal-title":"Cancers"},{"key":"10289_CR156","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.cbpa.2017.03.011","volume":"38","author":"Z Qian","year":"2017","unstructured":"Qian Z, Dougherty PG, Pei D (2017) Targeting intracellular protein\u2013protein interactions with cell-permeable cyclic peptides. Curr Opin Chem Biol 38:80\u201386. https:\/\/doi.org\/10.1016\/j.cbpa.2017.03.011","journal-title":"Curr Opin Chem Biol"},{"key":"10289_CR157","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-017-0328-x","author":"S Marqus","year":"2017","unstructured":"Marqus S, Pirogova E, Piva TJ (2017) Evaluation of the use of therapeutic peptides for cancer treatment. J Biomed Sci. https:\/\/doi.org\/10.1186\/s12929-017-0328-x","journal-title":"J Biomed Sci"},{"key":"10289_CR158","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1038\/nrd2590","volume":"7","author":"EM Driggers","year":"2008","unstructured":"Driggers EM, Hale SP, Lee J, Terrett NK (2008) The exploration of macrocycles for drug discovery\u2014an underexploited structural class. Nat Rev Drug Discov 7:608\u2013624. https:\/\/doi.org\/10.1038\/nrd2590","journal-title":"Nat Rev Drug Discov"},{"key":"10289_CR159","doi-asserted-by":"publisher","first-page":"557","DOI":"10.3390\/genes9110557","volume":"9","author":"D Gang","year":"2018","unstructured":"Gang D, Kim DW, Park H-S (2018) Cyclic peptides: promising scaffolds for biopharmaceuticals. Genes 9:557. https:\/\/doi.org\/10.3390\/genes9110557","journal-title":"Genes"},{"key":"10289_CR160","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1007\/s13238-014-0089-1","volume":"5","author":"S Xiong","year":"2014","unstructured":"Xiong S, Mu T, Wang G, Jiang X (2014) Mitochondria-mediated apoptosis in mammals. Protein Cell 5:737\u2013749. https:\/\/doi.org\/10.1007\/s13238-014-0089-1","journal-title":"Protein Cell"},{"key":"10289_CR161","doi-asserted-by":"publisher","first-page":"4569","DOI":"10.1021\/ol801799d","volume":"10","author":"W-J Xu","year":"2008","unstructured":"Xu W-J, Liao X-J, Xu S-H, Diao J-Z, Du B, Zhou X-L, Pan S-S (2008) Isolation, structure determination, and synthesis of Galaxamide, a rare cytotoxic cyclic pentapeptide from a marine algae Galaxaura filamentosa. Org Lett 10:4569\u20134572. https:\/\/doi.org\/10.1021\/ol801799d","journal-title":"Org Lett"},{"key":"10289_CR162","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/8392035","author":"J Lunagariya","year":"2017","unstructured":"Lunagariya J, Liao X, Long W, Zhong S, Bhadja P, Li H, Zhao B, Xu S (2017) Cytotoxicity study of cyclopentapeptide analogues of marine natural product galaxamide towards human breast cancer cells. Oxid Med Cell Longev. https:\/\/doi.org\/10.1155\/2017\/8392035","journal-title":"Oxid Med Cell Longev"},{"key":"10289_CR163","doi-asserted-by":"publisher","first-page":"115933","DOI":"10.1016\/j.carbpol.2020.115933","volume":"235","author":"Q Zhu","year":"2020","unstructured":"Zhu Q, Liu S, Sun J, Liu J, Kirubaharan CJ, Chen H, Xu W, Wang Q (2020) Stimuli-responsive cellulose nanomaterials for smart applications. Carbohydr Polym 235:115933. https:\/\/doi.org\/10.1016\/j.carbpol.2020.115933","journal-title":"Carbohydr Polym"},{"key":"10289_CR164","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.jconrel.2020.08.020","volume":"327","author":"Y Dong","year":"2020","unstructured":"Dong Y, Hengst L, Hunt R, Feng X, Kozak D, Choi S, Ashraf M, Xu X (2020) Evaluating drug distribution and release in ophthalmic emulsions: impact of release conditions. J Control Release 327:360\u2013370. https:\/\/doi.org\/10.1016\/j.jconrel.2020.08.020","journal-title":"J Control Release"},{"key":"10289_CR165","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.bbrc.2019.06.088","volume":"516","author":"Z Qin","year":"2019","unstructured":"Qin Z, Zheng X, Fang Y (2019) Long noncoding RNA TMPO-AS1 promotes progression of non-small cell lung cancer through regulating its natural antisense transcript TMPO. Biochem Biophys Res Commun 516:486\u2013493. https:\/\/doi.org\/10.1016\/j.bbrc.2019.06.088","journal-title":"Biochem Biophys Res Commun"},{"key":"10289_CR166","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1002\/med.21542","volume":"39","author":"J Wang","year":"2018","unstructured":"Wang J, Dou X, Song J, Lyu Y, Zhu X, Xu L, Li W, Shan A (2018) Antimicrobial peptides: promising alternatives in the post feeding antibiotic era. Med Res Rev 39:831\u2013859. https:\/\/doi.org\/10.1002\/med.21542","journal-title":"Med Res Rev"},{"key":"10289_CR167","doi-asserted-by":"publisher","DOI":"10.4155\/fdd-2022-0005","author":"C Lamers","year":"2022","unstructured":"Lamers C (2022) Overcoming the shortcomings of peptide-based therapeutics. Future Drug Discov. https:\/\/doi.org\/10.4155\/fdd-2022-0005","journal-title":"Future Drug Discov"},{"key":"10289_CR168","doi-asserted-by":"publisher","first-page":"4167","DOI":"10.1021\/jacs.8b13178","volume":"141","author":"AA Vinogradov","year":"2019","unstructured":"Vinogradov AA, Yin Y, Suga H (2019) Macrocyclic peptides as drug candidates: recent progress and remaining challenges. J Am Chem Soc 141:4167\u20134181. https:\/\/doi.org\/10.1021\/jacs.8b13178","journal-title":"J Am Chem Soc"},{"key":"10289_CR169","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1080\/10717544.2018.1501119","volume":"25","author":"J Reinholz","year":"2018","unstructured":"Reinholz J, Landfester K, Mail\u00e4nder V (2018) The challenges of oral drug delivery via nanocarriers. Drug Deliv 25:1694\u20131705. https:\/\/doi.org\/10.1080\/10717544.2018.1501119","journal-title":"Drug Deliv"}],"container-title":["The Protein Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10930-025-10289-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10930-025-10289-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10930-025-10289-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T17:28:40Z","timestamp":1762536520000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10930-025-10289-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,5]]},"references-count":169,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10289"],"URL":"https:\/\/doi.org\/10.1007\/s10930-025-10289-2","relation":{},"ISSN":["1572-3887","1875-8355"],"issn-type":[{"value":"1572-3887","type":"print"},{"value":"1875-8355","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,5]]},"assertion":[{"value":"23 August 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human and animal subjects performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Standards"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}